Canada Proposes Amendments to Adverse Drug Reaction Reporting

October 2009

Teresa A. Reguly

Tags:

Advertising and Marketing Food and Drug Regulatory Intellectual Property Life Sciences Pharmaceuticals

Related Expertise

Related Insights

Back